Literature DB >> 7021023

Murine lupus nephritis is accelerated by anti-glomerular basement membrane autoantibodies.

U H Rudofsky.   

Abstract

We have tested the effect of deposition of non-pathogenic amounts of induced anti-glomerular basement membrane (GBM) autoantibodies on the development of the spontaneous lupus nephritis of female (NZB x NZW) F1 (B x W) mice. Female and male B x W mice were immunized with rabbit renal tubular basement membrane in adjuvant at 2 months of age and their kidneys were examined 35 to 66 days later; control B x W mice were injected with adjuvant only or remained untreated. By immunofluorescent and histopathological criteria, only the 4-month-old female B x W mice with anti-GBM autoantibody deposits had an accelerated onset of lupus nephritis resembling the findings not seen until 6 to 8 months of age in unmanipulated mice. Thus potentially pathogenic amounts of immune complexes are present in young female B x W mice, but these do not deposit in glomeruli until much later in life. Evidently, the anti-GBM autoantibodies modified the glomerular milieu sufficiently to facilitate accelerated immune complex deposition.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021023      PMCID: PMC1537207     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  9 in total

Review 1.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection.

Authors:  A J Rees; C M Lockwood; D K Peters
Journal:  Br Med J       Date:  1977-09-17

3.  The interaction of anti-glomerular basement membrane antibody deposition with immune elimination of bovine serum albumin in the rabbit.

Authors:  P Trevillian; J S Cameron
Journal:  Clin Exp Immunol       Date:  1979-03       Impact factor: 4.330

4.  The ubiquitous occurrence of immune complex localization in the renal glomeruli of normal mice.

Authors:  R V Markham; J C Sutherland; M R Mardiney
Journal:  Lab Invest       Date:  1973-07       Impact factor: 5.662

5.  In situ immune complex formation and glomerular injury.

Authors:  W G Couser; D J Salant
Journal:  Kidney Int       Date:  1980-01       Impact factor: 10.612

6.  Susceptibility differences of inbred mice to induction of autoimmune renal tubulointerstitial lesions.

Authors:  U H Rudofsky; R L Dilwith; K S Tung
Journal:  Lab Invest       Date:  1980-11       Impact factor: 5.662

7.  Spontaneous and induced autoantibodies to renal and nonrenal basement membranes in mice.

Authors:  U H Rudofsky
Journal:  Clin Immunol Immunopathol       Date:  1980-02

8.  Sequential study of C 1 q-binding substances and of anti-DNA antibodies in (NZB X NZW)F1 mice: evidence for an acute phase of the lupus disease in 2-month-old mice.

Authors:  G J Fournié; M Gayral-Ta Minh; S Haas; J P Pourrat; J J Conte
Journal:  Eur J Immunol       Date:  1979-08       Impact factor: 5.532

9.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

  9 in total
  2 in total

1.  Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.

Authors:  Yudong Liu; Yaíma L Lightfoot; Nickie Seto; Carmelo Carmona-Rivera; Erica Moore; Rishi Goel; Liam O'Neil; Pragnesh Mistry; Victoria Hoffmann; Santanu Mondal; Padmavathy Nandha Premnath; Katherine Gribbons; Stefania Dell'Orso; Kan Jiang; Paul R Thompson; Hong-Wei Sun; Scott A Coonrod; Mariana J Kaplan
Journal:  JCI Insight       Date:  2018-12-06

2.  Novel biomarkers for the assessment of paediatric systemic lupus erythematosus nephritis.

Authors:  A Koutsonikoli; M Trachana; E Farmaki; V Tzimouli; P Pratsidou-Gertsi; N Printza; A Garyphallos; V Galanopoulou; F Kanakoudi-Tsakalidou; F Papachristou
Journal:  Clin Exp Immunol       Date:  2017-01-22       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.